Home - Products - Others - Other Targets - 6-Formyl-isoophiopogonanone B

6-Formyl-isoophiopogonanone B

CAS No. 88700-30-5

6-Formyl-isoophiopogonanone B( ——— )

Catalog No. M38293 CAS No. 88700-30-5

6-Formyl-isoophiopogonanone B is a homoisoflavonoid, which can be isolated from Ophiopogon japonicus.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    6-Formyl-isoophiopogonanone B
  • Note
    Research use only, not for human use.
  • Brief Description
    6-Formyl-isoophiopogonanone B is a homoisoflavonoid, which can be isolated from Ophiopogon japonicus.
  • Description
    6-Formyl-isoophiopogonanone B is a homoisoflavonoid, which can be isolated from Ophiopogon japonicus.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    88700-30-5
  • Formula Weight
    342.34
  • Molecular Formula
    C19H18O6
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ye M, et al. Analysis of homoisoflavonoids in Ophiopogon japonicus by HPLC-DAD-ESI-MSn. J Am Soc Mass Spectrom. 2005 Feb;16(2):234-43. ?
molnova catalog
related products
  • Cavidine

    Cavidine ((+)-Cavidine) is a selective COX-2 inhibitor which possesses anti-inflammatory activity. Cavidine can be used for the research of skin injuries, hepatitis, cholecystitis, and scabies. Cavidine ameliorates LPS -induced acute lung injury via NF-κB signaling pathway.

  • Benzylurea

    Benzylurea competitively inhibits dehydrogenase/cytokinin oxidase.

  • Dermorphin TFA

    Dermorphin TFA is a new class of opioids-like peptides.